1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Dr. Jan-Anders Karlsson |
2 |
Reason for the notification |
a)
|
Position/status
|
Chief Executive Officer |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Verona Pharma plc |
b) |
LEI |
n/a |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 0.1 pence each GB00B06GSH43 |
b) |
Nature of the transaction |
Jan-Anders Karlsson purchased 600,000 Ordinary Shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
3.249 pence per Ordinary Share |
600,000 Ordinary Shares |
|
d) |
Aggregated information - Aggregated volume - Price
|
600,000 Ordinary Shares at 3.249 pence per Ordinary Share |
e) |
Date of the transaction |
9 August 2016 |
f) |
Place of the transaction |
London Stock Exchange, AIM |